Our results showed that several cytokines such as IFN-γ, TNF-α, IL-2, IL-6, and GM-CSF were significantly reduced in the plasma of gastric cancer patients following repeated cycles of fluoropyrimidine treatment, especially after two cycles, suggesting that the functions of T cells and immune responses were impaired by fluoropyrimidine. This evidence concerns the gene IL2 and gastric cancer.